Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis

Open access

Abstract

Genome damage and defective repair are etiologically linked to neurodegeneration. However, the specific mechanisms involved remain enigmatic. Here, we identify defects in DNA nick ligation and oxidative damage repair in a subset of amyotrophic lateral sclerosis (ALS) patients. These defects are caused by mutations in the RNA/DNA-binding protein FUS. In healthy neurons, FUS protects the genome by facilitating PARP1-dependent recruitment of XRCC1/DNA Ligase IIIα (LigIII) to oxidized genome sites and activating LigIII via direct interaction. We discover that loss of nuclear FUS caused DNA nick ligation defects in motor neurons due to reduced recruitment of XRCC1/LigIII to DNA strand breaks. Moreover, DNA ligation defects in ALS patient-derived iPSC lines carrying FUS mutations and in motor neurons generated therefrom are rescued by CRISPR/Cas9-mediated correction of mutation. Our findings uncovered a pathway of defective DNA ligation in FUS-linked ALS and suggest that LigIII-targeted therapies may prevent or slow down disease progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-06111-6

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Loss of FUS induces SSB accumulation and ROS sensitization. a, b Immunoblot (IB) showing FUS knockdown (KD) by shRNAs. Total lysate were extracted from SH-SY5Y cells 48 h after the transfection with two individual FUS shRNAs. β-actin was probed as loading control. Quantitation of relative band intensity of FUS shRNA vs Control shRNA shown in b. The error bars are standard deviation of experiments performed in triplicate (***p < 0.001, two-tailed unpaired Student’s t-test). c Alkaline and neutral comet assay of control vs FUS KD SH-SY5Y cells. The quantitation of mean tail moment from 50 randomly selected nuclei is shown in the histogram. The error bars are standard deviation. (**p < 0.01, two-tailed unpaired Student’s t-test). d, e MTT-based viability analysis of FUS KD SH-SY5Y cells, treated with increasing doses of GO or H2O2. The cells were incubated with GO for 1 h or H2O2 as indicated dose for 3 h, 48 h after the FUS shRNA transfection. MTT assay was performed 24 h after the treatment. The error bars are standard deviation of experiment performed in triplicate (**p < 0.01; ***p < 0.001, two-tailed unpaired Student’s t-test). f Clonogenic survival analysis of FUS KD HEK293 cells after GO (100 ng/ml) treatment, as in Fig. 1c. The error bars are standard deviation of experiment performed in triplicate. g, h Repair kinetics of induced oxidative genome damage after FUS KD. Alkaline comet assay of control or FUS knockdown SH-SY5Y cells at 0, 30, and 150 min post GO (100 ng/ml) treatment. Histogram represent quantitation of mean tail moment from 50 randomly selected nuclei. The error bars are standard deviation (*p < 0.05; **p < 0.01; ***p < 0.001, two-tailed unpaired Student’s t-test)
Fig. 1 Loss of FUS induces SSB accumulation and ROS sensitization. a, b Immunoblot (IB) showing FUS knockdown (KD) by shRNAs. Total lysate were extracted from SH-SY5Y cells 48 h after the transfection with two individual FUS shRNAs. β-actin was probed as loading control. Quantitation of relative band intensity of FUS shRNA vs Control shRNA shown in b. The error bars are standard deviation of experiments performed in triplicate (***p < 0.001, two-tailed unpaired Student’s t-test). c Alkaline and neutral comet assay of control vs FUS KD SH-SY5Y cells. The quantitation of mean tail moment from 50 randomly selected nuclei is shown in the histogram. The error bars are standard deviation. (**p < 0.01, two-tailed unpaired Student’s t-test). d, e MTT-based viability analysis of FUS KD SH-SY5Y cells, treated with increasing doses of GO or H2O2. The cells were incubated with GO for 1 h or H2O2 as indicated dose for 3 h, 48 h after the FUS shRNA transfection. MTT assay was performed 24 h after the treatment. The error bars are standard deviation of experiment performed in triplicate (**p < 0.01; ***p < 0.001, two-tailed unpaired Student’s t-test). f Clonogenic survival analysis of FUS KD HEK293 cells after GO (100 ng/ml) treatment, as in Fig. 1c. The error bars are standard deviation of experiment performed in triplicate. g, h Repair kinetics of induced oxidative genome damage after FUS KD. Alkaline comet assay of control or FUS knockdown SH-SY5Y cells at 0, 30, and 150 min post GO (100 ng/ml) treatment. Histogram represent quantitation of mean tail moment from 50 randomly selected nuclei. The error bars are standard deviation (*p < 0.05; **p < 0.01; ***p < 0.001, two-tailed unpaired Student’s t-test)CC BY · PubMed Central
Fig. 2 FUS forms a complex with PARP1, XRCC1, and LigIII. a IB of Flag-FUS co-Immunoprecipitation (co-IP) from HEK293 cells for oxidative DNA damage repair proteins with or without GO treatment (100 ng/ml for 1 h). The IP was performed with anti-Flag antibody. b IB of endogenous FUS co-IP from SH-SY5Y cells for PARP1, XRCC1, and LigIII. The IP was performed with anti-FUS antibody. c Scheme of human iPSC line differentiation to motor neurons. Representative phase-contrast images of iPSC and differentiated motor neurons are shown. Scale bar = 50 µm. d Immunofluorescence (IF) staining of motor neuron markers. Representative images of motor neurons that stained Isl-1, MAP2, or βIII-tubulin indicated ~80% differentiation efficiency. Scale bar = 50 µm. e IB of endogenous FUS co-IP from differentiated motor neurons for PARP1, XRCC1, and LigIII. f Quantitation of IB band intensity in Fig. 2b, e to show level change of PARP-1, XRCC1, and LigIII in FUS IP after GO treatment. The error bars are standard deviation of experiments performed in triplicate. g PLA of FUS vs PARP1, XRCC1, or LigIII in SH-SY5Y and iPSC-derived motor neurons with or without GO treatment. Nuclei stained with DAPI. Scale bar = 5 µm. h Quantitation of PLA foci from 25 motor neuronal cells (**p < 0.01, two-tailed unpaired Student’s t-test). The error bars are standard deviation
Fig. 2 FUS forms a complex with PARP1, XRCC1, and LigIII. a IB of Flag-FUS co-Immunoprecipitation (co-IP) from HEK293 cells for oxidative DNA damage repair proteins with or without GO treatment (100 ng/ml for 1 h). The IP was performed with anti-Flag antibody. b IB of endogenous FUS co-IP from SH-SY5Y cells for PARP1, XRCC1, and LigIII. The IP was performed with anti-FUS antibody. c Scheme of human iPSC line differentiation to motor neurons. Representative phase-contrast images of iPSC and differentiated motor neurons are shown. Scale bar = 50 µm. d Immunofluorescence (IF) staining of motor neuron markers. Representative images of motor neurons that stained Isl-1, MAP2, or βIII-tubulin indicated ~80% differentiation efficiency. Scale bar = 50 µm. e IB of endogenous FUS co-IP from differentiated motor neurons for PARP1, XRCC1, and LigIII. f Quantitation of IB band intensity in Fig. 2b, e to show level change of PARP-1, XRCC1, and LigIII in FUS IP after GO treatment. The error bars are standard deviation of experiments performed in triplicate. g PLA of FUS vs PARP1, XRCC1, or LigIII in SH-SY5Y and iPSC-derived motor neurons with or without GO treatment. Nuclei stained with DAPI. Scale bar = 5 µm. h Quantitation of PLA foci from 25 motor neuronal cells (**p < 0.01, two-tailed unpaired Student’s t-test). The error bars are standard deviationCC BY · PubMed Central
Fig. 3 FUS activates LigIII for DNA ligation via direct interaction. a In vitro affinity co-elution of purified GST-FUS with XRCC1/LigIII complex, or XRCC1, LigIII, and PARP1 separately. GST or GST-FUS was detected by coomassie staining (left panel) or IB. XRCC1, LigIII and PARP1 were detected by IB. b and c. In vitro DNA nick ligation activity assay. Increasing amounts of FUS (10–500 f.moles) was incubated with XRCC1/LigIII complex (100 f.moles) in a reaction mixture containing 5′ cy3-labeled duplex oligonucleotide substrate carrying a single-strand nick in the middle (top). The reaction was stoped after 30 min and the products were separated by electrophoresis under denaturing conditions. Quantitation of fold change in ligated products (c). The error bars are standard deviation of experiments performed in triplicate (***p < 0.001, two-tailed unpaired Student’s t-test). d–f Measurement of kinetic parameters of FUS-induced activation of LigIII. Increasing amounts (0–500 nM) of cold (unlabeled) ligation substrate was mixed in a ligation reaction as in Fig. 3b containing XRCC1/LigIII with or without FUS, together with containing 50fM cy3-labeled substrate. The reaction was stopped after 5 min. e The plot of the reaction rate (V) vs. substrate concentration. The kinetic parameters Km and Kcat were calculated by Lineweaver–Burk plot of 1/V vs. 1/S (f). g Tabulation of kinetic parameters. All error bars are standard deviation of three independent experiments
Fig. 3 FUS activates LigIII for DNA ligation via direct interaction. a In vitro affinity co-elution of purified GST-FUS with XRCC1/LigIII complex, or XRCC1, LigIII, and PARP1 separately. GST or GST-FUS was detected by coomassie staining (left panel) or IB. XRCC1, LigIII and PARP1 were detected by IB. b and c. In vitro DNA nick ligation activity assay. Increasing amounts of FUS (10–500 f.moles) was incubated with XRCC1/LigIII complex (100 f.moles) in a reaction mixture containing 5′ cy3-labeled duplex oligonucleotide substrate carrying a single-strand nick in the middle (top). The reaction was stoped after 30 min and the products were separated by electrophoresis under denaturing conditions. Quantitation of fold change in ligated products (c). The error bars are standard deviation of experiments performed in triplicate (***p < 0.001, two-tailed unpaired Student’s t-test). d–f Measurement of kinetic parameters of FUS-induced activation of LigIII. Increasing amounts (0–500 nM) of cold (unlabeled) ligation substrate was mixed in a ligation reaction as in Fig. 3b containing XRCC1/LigIII with or without FUS, together with containing 50fM cy3-labeled substrate. The reaction was stopped after 5 min. e The plot of the reaction rate (V) vs. substrate concentration. The kinetic parameters Km and Kcat were calculated by Lineweaver–Burk plot of 1/V vs. 1/S (f). g Tabulation of kinetic parameters. All error bars are standard deviation of three independent experimentsCC BY · PubMed Central
Fig. 4 DNA ligation defects in CRSPR/Cas9-mediated FUS KO cells. a Scheme of CRISPR/Cas9 targeting of FUS. Images indicate stable expression of GFP-Cas9 in HEK293 cells. Scale bar = 50 µm. b IB of endogenous FUS, PARP1, XRCC1 and LigIII in FUS WT and FUS KO HEK293 cells. β-actin was probed as loading control. c, d In vitro DNA nick ligation activity assay. XRCC1 IP complex from nuclear extract of GO-treated FUS WT and FUS KO HEK293 cells, was incubated with or without purified FUS. d Quantitation of ligation activity (**p < 0.01, two-tailed unpaired Student’s t-test). e IF of ectopically expressed Flag-FUS WT and Flag-FUS P525L mutant in HEK293 cells. Endogenous FUS depleted using UTR-specific shRNA. IF was performed by anti-Flag antibody 48 h after the co-transfection of FUS shRNA with either Flag-FUS WT or Flag-FUS P525L plasmid. DAPI staining indicates nucleus. Scale bar = 5 µm. f In vitro DNA nick ligation assay. Rescue of DNA ligation defect in FUS KD HEK293 cells by WT vs P525L mutant FUS expression. XRCC1 IP complex from nuclear extract of GO-treated FUS KD HEK293 cells with or without ectopic FUS WT and FUS P525L expression. The quantitation of ligation activity is shown in the histogram (bottom). g IB of cell extract used in f to confirm the comparable level of PARP1, XRCC1, and LigIII in WT or mutant FUS expressing cells. β-actin was probed as loading control. All error bars are standard deviation of experiments performed in triplicate
Fig. 4 DNA ligation defects in CRSPR/Cas9-mediated FUS KO cells. a Scheme of CRISPR/Cas9 targeting of FUS. Images indicate stable expression of GFP-Cas9 in HEK293 cells. Scale bar = 50 µm. b IB of endogenous FUS, PARP1, XRCC1 and LigIII in FUS WT and FUS KO HEK293 cells. β-actin was probed as loading control. c, d In vitro DNA nick ligation activity assay. XRCC1 IP complex from nuclear extract of GO-treated FUS WT and FUS KO HEK293 cells, was incubated with or without purified FUS. d Quantitation of ligation activity (**p < 0.01, two-tailed unpaired Student’s t-test). e IF of ectopically expressed Flag-FUS WT and Flag-FUS P525L mutant in HEK293 cells. Endogenous FUS depleted using UTR-specific shRNA. IF was performed by anti-Flag antibody 48 h after the co-transfection of FUS shRNA with either Flag-FUS WT or Flag-FUS P525L plasmid. DAPI staining indicates nucleus. Scale bar = 5 µm. f In vitro DNA nick ligation assay. Rescue of DNA ligation defect in FUS KD HEK293 cells by WT vs P525L mutant FUS expression. XRCC1 IP complex from nuclear extract of GO-treated FUS KD HEK293 cells with or without ectopic FUS WT and FUS P525L expression. The quantitation of ligation activity is shown in the histogram (bottom). g IB of cell extract used in f to confirm the comparable level of PARP1, XRCC1, and LigIII in WT or mutant FUS expressing cells. β-actin was probed as loading control. All error bars are standard deviation of experiments performed in triplicateCC BY · PubMed Central
Fig. 5 Defective DNA repair in ALS patient-derived iPSC line. a The location of familial FUS mutations R521H and P525L indicated in FUS protein sequence. b, c IB of nuclear and cytosolic extracts isolated from ALS patient-derived fibroblasts, probed for FUS. H2AXII and β-actin were probed as loading control. Histogram shows quantitation of IB band intensity. The error bars are standard deviation of experiments performed in triplicate (*p < 0.05, two-tailed unpaired Student’s t-test). d, e Integrity of genomic DNA isolated from ALS patient-derived fibroblasts measured by long amplicon quantitative PCR (LA-PCR) analysis. 10.4 kb fragment including exons 2–5 of the hprt gene was amplified and separated in 1% agarose gel. The amplified DNA product was quantified using pico green fluorescence. The error bars are standard deviation of experiments performed in triplicate (**p < 0.01, two-tailed unpaired Student’s t-test). f IF motor neurons for FUS to analyze its nucleus vs. cytosolic distribution. Nuclei stained with DAPI. Zoomed images on right showing FUS distribution in arrow indicated nuclear. Scale bar = 10 µm. g, h LA-PCR-based DNA damage repair kinetic analysis. Genome DNA extracted from iPSC-derived motor neurons at indicated time points after release from exposure to GO (100 ng/ml) for 1 h. Amplification products analyzed by agarose gel electrophoresis or pico green-based quantitation as in Fig. 6d,e. The error bars are standard deviation of experiments performed in triplicate. i, j TUNEL analysis of motor neurons carrying FUS WT or FUS R521H or P525L mutation. Motor neurons differentiated from ALS patients derived iPSC lines were treated with H2O2 (100 μM for 3 h), and cells were subjected to TUNEL assay 24 h after the release from treatment. Scale bar = 50 µm. Histogram shows quantitation of TUNEL-positive nuclei from 200 cells in total. The error bars are standard deviation (*p < 0.05, two-tailed unpaired Student’s t-test)
Fig. 5 Defective DNA repair in ALS patient-derived iPSC line. a The location of familial FUS mutations R521H and P525L indicated in FUS protein sequence. b, c IB of nuclear and cytosolic extracts isolated from ALS patient-derived fibroblasts, probed for FUS. H2AXII and β-actin were probed as loading control. Histogram shows quantitation of IB band intensity. The error bars are standard deviation of experiments performed in triplicate (*p < 0.05, two-tailed unpaired Student’s t-test). d, e Integrity of genomic DNA isolated from ALS patient-derived fibroblasts measured by long amplicon quantitative PCR (LA-PCR) analysis. 10.4 kb fragment including exons 2–5 of the hprt gene was amplified and separated in 1% agarose gel. The amplified DNA product was quantified using pico green fluorescence. The error bars are standard deviation of experiments performed in triplicate (**p < 0.01, two-tailed unpaired Student’s t-test). f IF motor neurons for FUS to analyze its nucleus vs. cytosolic distribution. Nuclei stained with DAPI. Zoomed images on right showing FUS distribution in arrow indicated nuclear. Scale bar = 10 µm. g, h LA-PCR-based DNA damage repair kinetic analysis. Genome DNA extracted from iPSC-derived motor neurons at indicated time points after release from exposure to GO (100 ng/ml) for 1 h. Amplification products analyzed by agarose gel electrophoresis or pico green-based quantitation as in Fig. 6d,e. The error bars are standard deviation of experiments performed in triplicate. i, j TUNEL analysis of motor neurons carrying FUS WT or FUS R521H or P525L mutation. Motor neurons differentiated from ALS patients derived iPSC lines were treated with H2O2 (100 μM for 3 h), and cells were subjected to TUNEL assay 24 h after the release from treatment. Scale bar = 50 µm. Histogram shows quantitation of TUNEL-positive nuclei from 200 cells in total. The error bars are standard deviation (*p < 0.05, two-tailed unpaired Student’s t-test)CC BY · PubMed Central
Fig. 6 Correction of FUS mutations rescue DNA ligation defects. a Scheme of correction of FUS mutation in familial ALS patient-derived iPSC lines by CRISPR knock-in to generate isogenic control lines and their differentiation to motor neurons. b IF motor neurons for FUS to analyze its nucleus vs. cytosolic distribution. Nuclei stained with DAPI. Zoomed images on right showing FUS distribution in arrow indicated nuclear. Scale bar = 10 µm. c, d In vitro DNA ligation assay. XRCC1 IP complex from nuclear extract of mutant and isogenic control motor neurons and quantified (**p < 0.01; ***p < 0.001, two-tailed unpaired Student’s t-test). e LA-PCR-based DNA damage repair kinetic analysis. Genome DNA extracted from iPSC-derived motor neurons at indicated time points after release from exposure to GO (100 ng/ml) for 1 h. Amplification products analyzed by pico green-based quantitation. All error bars are standard deviation of experiments performed in triplicate
Fig. 6 Correction of FUS mutations rescue DNA ligation defects. a Scheme of correction of FUS mutation in familial ALS patient-derived iPSC lines by CRISPR knock-in to generate isogenic control lines and their differentiation to motor neurons. b IF motor neurons for FUS to analyze its nucleus vs. cytosolic distribution. Nuclei stained with DAPI. Zoomed images on right showing FUS distribution in arrow indicated nuclear. Scale bar = 10 µm. c, d In vitro DNA ligation assay. XRCC1 IP complex from nuclear extract of mutant and isogenic control motor neurons and quantified (**p < 0.01; ***p < 0.001, two-tailed unpaired Student’s t-test). e LA-PCR-based DNA damage repair kinetic analysis. Genome DNA extracted from iPSC-derived motor neurons at indicated time points after release from exposure to GO (100 ng/ml) for 1 h. Amplification products analyzed by pico green-based quantitation. All error bars are standard deviation of experiments performed in triplicateCC BY · PubMed Central
Fig. 7 Dominant negative activity of the R521H FUS mutation. a, b Recruitment of GFP-FUS at laser ablation track by live cell imaging. Representative images of ectopic GFP-FUS WT or R521H/C mutant following laser ablation. GFP-FUS WT or R521H/C was transfected into HEK293 cells and subjected to laser ablation 48 h after the transfection. The recruitment of GFP fluorescence at laser tracks was monitored by live cell imaging (see movie clip in Supplementary Movie 1, 2 and 3 for live imaging). Scale bar = 1 µm. b Quantification of GFP-FUS track intensity from 15 cells is shown in histogram. The error bars are standard deviation. c Representative IF images of GFP-FUS WT or R521H/C mutant in HEK293 cells without laser treatment. Scale bar = 5 µm. d, e PLA of FUS vs XRCC1, LigIII and PARP1 in iPSC carrying FUS WT or FUS R521H after GO treatment. Representative images shown in d and average number of PLA foci from 25 cells were quantified in e. The error bars are standard deviation (*p < 0.05, two-tailed unpaired Student’s t-test). Scale bar = 5 µm. f Quantification of FUS mRNA analyzed by RT-PCR in antisense oligonucleotide-incubated motor neurons at indicted concentrations. The error bars are standard deviation of experiments performed in triplicate. g, h IB showing FUS KD in f Histogram shows quantitation of IB band intensity (h). The error bars are standard deviation of experiments performed in triplicate. i, j In vitro DNA nick ligation activity assay. XRCC1 IP complex from GO-treated motor neurons with FUS WT, FUS KD, and FUS R521H, and quantified. The error bars are standard deviation of experiments performed in triplicate (*p < 0.05, two-tailed unpaired Student’s t-test)
Fig. 7 Dominant negative activity of the R521H FUS mutation. a, b Recruitment of GFP-FUS at laser ablation track by live cell imaging. Representative images of ectopic GFP-FUS WT or R521H/C mutant following laser ablation. GFP-FUS WT or R521H/C was transfected into HEK293 cells and subjected to laser ablation 48 h after the transfection. The recruitment of GFP fluorescence at laser tracks was monitored by live cell imaging (see movie clip in Supplementary Movie 1, 2 and 3 for live imaging). Scale bar = 1 µm. b Quantification of GFP-FUS track intensity from 15 cells is shown in histogram. The error bars are standard deviation. c Representative IF images of GFP-FUS WT or R521H/C mutant in HEK293 cells without laser treatment. Scale bar = 5 µm. d, e PLA of FUS vs XRCC1, LigIII and PARP1 in iPSC carrying FUS WT or FUS R521H after GO treatment. Representative images shown in d and average number of PLA foci from 25 cells were quantified in e. The error bars are standard deviation (*p < 0.05, two-tailed unpaired Student’s t-test). Scale bar = 5 µm. f Quantification of FUS mRNA analyzed by RT-PCR in antisense oligonucleotide-incubated motor neurons at indicted concentrations. The error bars are standard deviation of experiments performed in triplicate. g, h IB showing FUS KD in f Histogram shows quantitation of IB band intensity (h). The error bars are standard deviation of experiments performed in triplicate. i, j In vitro DNA nick ligation activity assay. XRCC1 IP complex from GO-treated motor neurons with FUS WT, FUS KD, and FUS R521H, and quantified. The error bars are standard deviation of experiments performed in triplicate (*p < 0.05, two-tailed unpaired Student’s t-test)CC BY · PubMed Central
Fig. 8 FUS facilitates PARP-1-dependent recruitment of XRCC1/LigIII. a, b Laser ablation microscopy for recruitment of GFP-XRCC1 after FUS knockdown. GFP-XRCC1 and FUS shRNA were co-transfected into HEK293 cells followed by laser treatment and microscopy 48 h after the transfection, as in Fig. 7a. Scale bar = 5 µm. Histogram shows the intensity of GFP-XRCC1 at laser track (see movie clip in Supplementary Movie 4 and 5 for live imaging). The error bars are standard deviation. c, d PLA of PARP1 vs XRCC1 and PARP-1 vs LigIII in WT or FUS mutant patient-derived motor neurons after GO treatment. Nuclei stained with DAPI. The average number of PLA foci from 25 cells were quantified. The error bars are standard deviation (*p < 0.05; **p < 0.01, two-tailed unpaired Student’s t-test). Scale bar = 5 µm. e, f XRCC1 co-IP (endogenous) from WT or FUS mutant patient-derived fibroblast lines and IB probed for PARP-1 and XRCC1. Histogram shows quantitation of IB band intensity. The error bars are standard deviation of experiments performed in triplicate (*p < 0.05, two-tailed unpaired Student’s t-test). g A model showing that PARP-1-dependent recruitment of XRCC1/LigIII at DNA SSBs is facilitated by FUS
Fig. 8 FUS facilitates PARP-1-dependent recruitment of XRCC1/LigIII. a, b Laser ablation microscopy for recruitment of GFP-XRCC1 after FUS knockdown. GFP-XRCC1 and FUS shRNA were co-transfected into HEK293 cells followed by laser treatment and microscopy 48 h after the transfection, as in Fig. 7a. Scale bar = 5 µm. Histogram shows the intensity of GFP-XRCC1 at laser track (see movie clip in Supplementary Movie 4 and 5 for live imaging). The error bars are standard deviation. c, d PLA of PARP1 vs XRCC1 and PARP-1 vs LigIII in WT or FUS mutant patient-derived motor neurons after GO treatment. Nuclei stained with DAPI. The average number of PLA foci from 25 cells were quantified. The error bars are standard deviation (*p < 0.05; **p < 0.01, two-tailed unpaired Student’s t-test). Scale bar = 5 µm. e, f XRCC1 co-IP (endogenous) from WT or FUS mutant patient-derived fibroblast lines and IB probed for PARP-1 and XRCC1. Histogram shows quantitation of IB band intensity. The error bars are standard deviation of experiments performed in triplicate (*p < 0.05, two-tailed unpaired Student’s t-test). g A model showing that PARP-1-dependent recruitment of XRCC1/LigIII at DNA SSBs is facilitated by FUSCC BY · PubMed Central
Fig. 9 Mutant FUS induces DNA ligation defects to inhibit oxidized damage repair. A model showing the involvement of FUS for optimal DNA nick ligation in healthy neurons to facilitate efficient oxidative genome damage repair, and how loss of functional FUS in ALS leads to DNA nick ligation defects. FUS is required for PARP-1-dependent recruitment of XRCC1/LigIII complex at oxidative DNA damage sites. Two familial FUS mutations impair DNA nick ligation by distinct mechanisms. Substantial cytoplasmic localization of P525L FUS causes DNA ligation defect due to loss of functional FUS from nucleus. The R521H/C FUS fails to form the repair complex with XRCC1/LigIII and PARP-1 and is not recruited at damage site. Unrepaired DNA SSBs caused by impaired DNA nick ligation, together with secondary DSBs that may be generated from closely placed single-strand breaks, may substantially contribute to neurodegeneration in familial FUS-ALS patients
Fig. 9 Mutant FUS induces DNA ligation defects to inhibit oxidized damage repair. A model showing the involvement of FUS for optimal DNA nick ligation in healthy neurons to facilitate efficient oxidative genome damage repair, and how loss of functional FUS in ALS leads to DNA nick ligation defects. FUS is required for PARP-1-dependent recruitment of XRCC1/LigIII complex at oxidative DNA damage sites. Two familial FUS mutations impair DNA nick ligation by distinct mechanisms. Substantial cytoplasmic localization of P525L FUS causes DNA ligation defect due to loss of functional FUS from nucleus. The R521H/C FUS fails to form the repair complex with XRCC1/LigIII and PARP-1 and is not recruited at damage site. Unrepaired DNA SSBs caused by impaired DNA nick ligation, together with secondary DSBs that may be generated from closely placed single-strand breaks, may substantially contribute to neurodegeneration in familial FUS-ALS patientsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 207

Metadata

Authors
Wang, H., Guo, W., Mitra, J., Hegde, P. M., Vandoorne, T., Eckelmann, B. J., Mitra, S., Tomkinson, A. E., Van Den Bosch, L., & Hegde, M. L.
Affiliations
  • Houston Methodist (US)
  • VIB-KU Leuven Center for Brain & Disease Research (BE)
  • Texas A&M Health Science Center (US)
  • University of New Mexico (US)
Corresponding author
Hegde, Muralidhar L.
Venue
Nature Communications
Published
2018-09-11
Volume
9
Issue
1
Pages
3683-3683
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2889934668
Cited by
205
References
67
Citations by year
2026: 10 · 2025: 21 · 2024: 30 · 2023: 33 · 2022: 28 · 2021: 24 · 2020: 31 · 2019: 26 · 2018: 1
FWCI
13.92
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Lirias (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Veterans Affairs (I01 BX002466, BX002466)
  • Muscular Dystrophy Association (MDA 294842, 294842)
  • Arizona State University
  • Fonds Wetenschappelijk Onderzoek
  • KU Leuven (C14/17/107)
  • Vlaamse regering
  • National Institutes of Health (BX002466, CA92584, NS088645)
  • Houston Methodist Research Institute
  • National Cancer Institute (P01CA092584)
  • National Institute of Neurological Disorders and Stroke (R01NS088645)
  • National Institute of Environmental Health Sciences (R01ES012512)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
amyotrophic lateral sclerosis, FUS mutations, oxidative DNA damage repair, DNA ligase III, XRCC1, PARP1, motor neurons, genomic damage, neurodegeneration, iPSC-derived motor neurons, CRISPR/Cas9 gene correction
MeSH terms
X-ray Repair Cross Complementing Protein 1, Amyotrophic Lateral Sclerosis, Cell Line, DNA, DNA Damage, DNA Repair, Genes, Dominant, Humans, Models, Biological, Mutation, Poly(ADP-ribose) Polymerases, DNA Ligases, Reactive Oxygen Species, Oxidative Stress, RNA-Binding Protein FUS, Gene Knockout Techniques, Induced Pluripotent Stem Cells, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. https://app.cochat.ai/papers/10.1038/s41467-018-06111-6
The paper
Wang, H., Guo, W., Mitra, J., Hegde, P. M., Vandoorne, T., Eckelmann, B. J., Mitra, S., Tomkinson, A. E., Van Den Bosch, L., & Hegde, M. L. (2018). Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nature Communications. https://doi.org/10.1038/s41467-018-06111-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.